Enrique A. Conterno
2014
In 2014, Enrique A. Conterno earned a total compensation of $3.9M as Senior Vice President and President, Lilly Diabetes at Lilly Eli & Co, a 29% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,235,839 |
|---|---|
| Non-Equity Incentive Plan | $435,342 |
| Salary | $682,890 |
| Stock Awards | $1,500,000 |
| Other | $40,973 |
| Total | $3,895,044 |
Conterno received $1.5M in stock awards, accounting for 39% of the total pay in 2014.
Conterno also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $435.3K in non-equity incentive plan, $682.9K in salary and $41K in other compensation.
Rankings
In 2014, Enrique A. Conterno's compensation ranked 2,192nd out of 13,032 executives tracked by ExecPay. In other words, Conterno earned more than 83.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,192 out of 13,032 | 83rd |
Division Manufacturing | 777 out of 4,967 | 84th |
Major group Chemicals And Allied Products | 245 out of 1,690 | 86th |
Industry group Drugs | 190 out of 1,369 | 86th |
Industry Pharmaceutical Preparations | 156 out of 1,042 | 85th |
Source: SEC filing on March 20, 2017.
Conterno's colleagues
We found four more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2014.
2014
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2014
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2014
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
2014
Michael Harrington
Lilly Eli & Co